At DiabSense, we're on a mission to transform diabetic foot care by empowering patients and healthcare providers with early detection tools. Our AI-powered, connected devices identify foot ulcer risks before they become life-threatening—reducing amputations, hospitalizations, and healthcare costs.
We introduce DiabSense, an AI-assisted, connected foot scanning solution with both clinical and at-home applications for proactive diabetic care.
FootScan Pro supports hospitals and clinics with advanced diagnostic tools, enabling clinicians to make informed decisions with complete patient history and thermal image comparisons.
45 million diabetic patients develop foot ulcers yearly. Our purpose is to bring down this number drastically by detecting infections before they spread.
Early Detect. Early Treat. Prevent Forever.
Driven by global collaboration and deep medical expertise
Headquartered in Estonia, with operations in Sri Lanka, DiabSense is powered by Exceltech OÜ, an expert in medical product development.
Our core team includes medical advisors, engineering experts, and business leaders collaborating globally to innovate solutions in diabetic care.
Powerful innovation meets simplicity in diabetic foot monitoring.
Combines thermal and visual foot imaging for deeper insights.
Scans work seamlessly across home and clinical environments.
Enables early detection and reduces risk of limb loss.
User-friendly design that's budget-friendly and portable.
Supported by real trials and trusted by medical professionals.
Advanced technology for real-time remote insights and alerts.
Unique innovation protected by pending patents.
We’re addressing a growing crisis with a proven solution.
$45 Billion
$4 Billion
$800 Million
in deep-diabetic stages
face amputations annually
develop ulcers